Geroscience approaches to increase healthspan and slow aging.

F1000Research

Volumn 5, Issue , 2016, Pages

  Melov, Simon ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CARDIOVASCULAR SYSTEM; GOLD STANDARD; HUMAN; LIFESPAN; MODEL; PRECLINICAL STUDY; SCIENTIST;

EID: 85010910630     PISSN: None     EISSN: 20461402     Source Type: Journal    
DOI: 10.12688/F1000RESEARCH.7583.1     Document Type: Review

References (112)

1. Johnson TE: Increased life-span of age-1 mutants in Caenorhabditis elegans and lower Gompertz rate of aging. Science. 1990; 249(4971): 908-12.
2. Friedman DB, Johnson TE: Three mutants that extend both mean and maximum life span of the nematode, Caenorhabditis elegans, define the age-1 gene. J Gerontol. 1988; 43(4): B102-9.
3. Johnson TE, Wood WB: Genetic analysis of life-span in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 1982; 79(21): 6603-7.
4. Morris JZ, Tissenbaum HA, Ruvkun G: A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature. 1996; 382(6591): 536-9.
5. Kenyon C, Chang J, Gensch E, et al.: A C. elegans mutant that lives twice as long as wild type. Nature. 1993; 366(6454): 461-4.
6. Kenyon CJ: The genetics of ageing. Nature. 2010; 464(7288): 504-12.
7. Clancy DJ, Gems D, Harshman LG, et al.: Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science. 2001; 292(5514): 104-6.
8. Sun J, Folk D, Bradley TJ, et al.: Induced overexpression of mitochondrial Mn-superoxide dismutase extends the life span of adult Drosophila melanogaster. Genetics. 2002; 161(2): 661-72.
9. Sun J, Molitor J, Tower J: Effects of simultaneous over-expression of Cu/ZnSOD and MnSOD on Drosophila melanogaster life span. Mech Ageing Dev. 2004; 125(5): 341-9.
10. Lin YJ, Seroude L, Benzer S: Extended life-span and stress resistance in the Drosophila mutant methuselah. Science. 1998; 282(5390): 943-6.
11. Bjedov I, Toivonen JM, Kerr F, et al.: Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. 2010; 11(1): 35-46.
12. Partridge L, Alic N, Bjedov I, et al.: Ageing in Drosophila: the role of the insulin/Igf and TOR signalling network. Exp Gerontol. 2011; 46(5): 376-81.
13. He Y, Jasper H: Studying aging in Drosophila. Methods. 2014; 68(1): 129-33.
14. Cannon L, Bodmer R: Genetic manipulation of cardiac ageing. J Physiol. 2016; 594(8): 2075-83.
15. Orr WC, Sohal RS: Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science. 1994; 263(5150): 1128-30.
16. Selman C, Withers DJ: Mammalian models of extended healthy lifespan. Philos Trans R Soc Lond B Biol Sci. 2011; 366(1561): 99-107.
17. Ladiges W, Van Remmen H, Strong R, et al.: Lifespan extension in genetically modified mice. Aging Cell. 2009; 8(4): 346-52.
18. Kennedy BK, Berger SL, Brunet A, et al.: Geroscience: linking aging to chronic disease. Cell. 2014; 159(4): 709-13.
19. Hurez V, Dao V, Liu A, et al.: Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice. Aging Cell. 2015; 14(6): 945-56.
20. Cabreiro F, Au C, Leung KY, et al.: Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell. 2013; 153(1): 228-39.
21. Oh SI, Park JK, Park SK: Lifespan extension and increased resistance to environmental stressors by N-acetyl-L-cysteine in Caenorhabditis elegans. Clinics (Sao Paulo). 2015; 70(5): 380-6.
22. Rangaraju S, Solis GM, Andersson SI, et al.: Atypical antidepressants extend lifespan of Caenorhabditis elegans by activation of a non-cell-autonomous stress response. Aging Cell. 2015; 14(6): 971-81.
23. Carretero M, Gomez-Amaro RL, Petrascheck M: Pharmacological classes that extend lifespan of Caenorhabditis elegans. Front Genet. 2015; 6: 77.
24. Lucanic M, Lithgow GJ, Alavez S: Pharmacological lifespan extension of invertebrates. Ageing Res Rev. 2013; 12(1): 445-58.
25. Neff F, Flores-Dominguez D, Ryan DP, et al.: Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest. 2013; 123(8): 3272-91.
26. Flynn JM, O'Leary MN, Zambataro CA, et al.: Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell. 2013; 12(5): 851-62.
27. Dai DF, Karunadharma PP, Chiao YA, et al.: Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart. Aging Cell. 2014; 13(3): 529-39.
28. Wilkinson JE, Burmeister L, Brooks SV, et al.: Rapamycin slows aging in mice. Aging Cell. 2012; 11(4): 675-82.
29. Evason K, Huang C, Yamben I, et al.: Anticonvulsant medications extend worm life-span. Science. 2005; 307(5707): 258-62.
30. Finch CE: Longevity, senescence, and the genome. Chicago, London: University of Chicago Press; 1990; 922.
31. Gems D: The aging-disease false dichotomy: understanding senescence as pathology. Front Genet. 2015; 6: 212.
32. Kirkwood TB: A systematic look at an old problem. Nature. 2008; 451(7179): 644-7.
33. López-Otín C, Blasco MA, Partridge L: The hallmarks of aging. Cell. 2013; 153(6): 1194-217.
34. Murphy MP, Partridge L: Toward a control theory analysis of aging. Annu Rev Biochem. 2008; 77: 777-98.
35. Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al.: Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in wellfunctioning older adults. Circulation. 2005; 111(25): 3384-90.
36. Klepin HD, Geiger AM, Tooze JA, et al.: Physical performance and subsequent disability and survival in older adults with malignancy: results from the health, aging and body composition study. J Am Geriatr Soc. 2010; 58(1): 76-82.
37. Schafer AL, Vittinghoff E, Lang TF, et al.: Fat infiltration of muscle, diabetes, and clinical fracture risk in older adults. J Clin Endocrinol Metab. 2010; 95(11): E368-72.
38. Abbatecola AM, Chiodini P, Gallo C, et al.: Pulse wave velocity is associated with muscle mass decline: Health ABC study. Age (Dordr). 2012; 34(2): 469-78.
39. Conroy MB, Kwoh CK, Krishnan E, et al.: Muscle strength, mass, and quality in older men and women with knee osteoarthritis. Arthritis Care Res (Hoboken). 2012; 64(1): 15-21.
40. Sarnak MJ, Katz R, Newman A, et al.: Association of urinary injury biomarkers with mortality and cardiovascular events. J Am Soc Nephrol. 2014; 25(7): 1545-53.
41. Nadkarni NK, Nunley KA, Aizenstein H, et al.: Association between cerebellar gray matter volumes, gait speed, and information-processing ability in older adults enrolled in the Health ABC study. J Gerontol A Biol Sci Med Sci. 2014; 69(8): 996-1003.
42. Arbeev KG, Ukraintseva SV, Akushevich I, et al.: Age trajectories of physiological indices in relation to healthy life course. Mech Ageing Dev. 2011; 132(3): 93-102.
43. White DK, Neogi T, Nevitt MC, et al.: Trajectories of gait speed predict mortality in well-functioning older adults: the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci. 2013; 68(4): 456-64.
44. Liu H, Graber TG, Ferguson-Stegall L, et al.: Clinically relevant frailty index for mice. J Gerontol A Biol Sci Med Sci. 2014; 69(12): 1485-91.
45. Carter CS, Sonntag WE, Onder G, et al.: Physical performance and longevity in aged rats. J Gerontol A Biol Sci Med Sci. 2002; 57(5): B193-7.
46. Hardy SE, Perera S, Roumani YF, et al.: Improvement in usual gait speed predicts better survival in older adults. J Am Geriatr Soc. 2007; 55(11): 1727-34.
47. Perera S, Patel KV, Rosano C, et al.: Gait Speed Predicts Incident Disability: A Pooled Analysis. J Gerontol A Biol Sci Med Sci. 2016; 71(1): 63-71.
48. Stowie AC, Glass JD: Longitudinal Study of Changes in Daily Activity Rhythms over the Lifespan in Individual Male and Female C57BL/6J Mice. J Biol Rhythms. 2015; 30(6): 563-8.
49. Hosono R: Age dependent changes in the behavior of Caenorhabditis elegans on attraction to Escherichia coli. Exp Gerontol. 1978; 13(1-2): 31-6.
50. Hosono R, Sato Y, Aizawa SI, et al.: Age-dependent changes in mobility and separation of the nematode Caenorhabditis elegans. Exp Gerontol. 1980; 15(4): 285-9.
51. Hosono R, Mitsui Y, Sato Y, et al.: Life span of the wild and mutant nematode Caenorhabditis elegans. Effects of sex, sterilization, and temperature. Exp Gerontol. 1982; 17(2): 163-72.
52. Iliadi KG, Boulianne GL: Age-related behavioral changes in Drosophila. Ann N Y Acad Sci. 2010; 1197: 9-18.
53. Herndon LA, Schmeissner PJ, Dudaronek JM, et al.: Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature. 2002; 419(6909): 808-14.
54. Hsu AL, Feng Z, Hsieh MY, et al.: Identification by machine vision of the rate of motor activity decline as a lifespan predictor in C. elegans. Neurobiol Aging. 2009; 30(9): 1498-503.
55. Ardekani R, Huang YM, Sancheti P, et al.: Using GFP video to track 3D movement and conditional gene expression in free-moving flies. PLoS One. 2012; 7(7): e40506.
56. Ardekani R, Biyani A, Dalton JE, et al.: Three-dimensional tracking and behaviour monitoring of multiple fruit flies. J R Soc Interface. 2013; 10(78): 20120547.
57. Ardekani R, Tavaré S, Tower J: Assessing senescence in Drosophila using video tracking. Methods Mol Biol. 2013; 965: 501-16.
58. Golden TR, Hubbard A, Dando C, et al.: Age-related behaviors have distinct transcriptional profiles in Caenorhabditis elegans. Aging Cell. 2008; 7(6): 850-65.
59. Bansal A, Zhu LJ, Yen K, et al.: Uncoupling lifespan and healthspan in Caenorhabditis elegans longevity mutants. Proc Natl Acad Sci U S A. 2015; 112(3): E277-86.
60. Hahm JH, Kim S, DiLoreto R, et al.: C. elegans maximum velocity correlates with healthspan and is maintained in worms with an insulin receptor mutation. Nat Commun. 2015; 6: 8919.
61. Seals DR, Melov S: Translational geroscience: emphasizing function to achieve optimal longevity. Aging (Albany NY). 2014; 6(9): 718-30.
62. Richardson A, Fischer KE, Speakman JR, et al.: Measures of Healthspan as Indices of Aging in Mice-A Recommendation. J Gerontol A Biol Sci Med Sci. 2016; 71(4): 427-30.
63. Johari S, Nock V, Alkaisi MM, et al.: High-Throughput Microfluidic Sorting of C. elegans for Automated Force Pattern Measurement. MSF. 2012; 700: 182-7.
64. Casadevalli Solvas X, Geier FM, Leroi AM, et al.: High-throughput age synchronisation of Caenorhabditis elegans. Chem Commun (Camb). 2011; 47(35): 9801-3.
65. Yuan J, Zhou J, Raizen DM, et al.: High-throughput, motility-based sorter for microswimmers such as C. elegans. Lab Chip. 2015; 15(13): 2790-8.
66. Zou S, Liedo P, Altamirano-Robles L, et al.: Recording lifetime behavior and movement in an invertebrate model. PLoS One. 2011; 6(4): e18151.
67. Tinkerhess MJ, Ginzberg S, Piazza N, et al.: Endurance training protocol and longitudinal performance assays for Drosophila melanogaster. J Vis Exp. 2012; (61): pii: 3786.
68. Evans W: Functional and metabolic consequences of sarcopenia. J Nutr. 1997; 127(5 Suppl): 998S-1003S.
69. Nilwik R, Snijders T, Leenders M, et al.: The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp Gerontol. 2013; 48(5): 492-8.
70. McLean RR, Kiel DP: Developing consensus criteria for sarcopenia: an update. J Bone Miner Res. 2015; 30(4): 588-92.
71. McGee MD, Weber D, Day N, et al.: Loss of intestinal nuclei and intestinal integrity in aging C. elegans. Aging Cell. 2011; 10(4): 699-710.
72. Golden TR, Beckman KB, Lee AH, et al.: Dramatic age-related changes in nuclear and genome copy number in the nematode Caenorhabditis elegans. Aging Cell. 2007; 6(2): 179-88.
73. McGee MD, Day N, Graham J, et al.: cep-1/p53-dependent dysplastic pathology of the aging C. elegans gonad. Aging (Albany NY). 2012; 4(4): 256-69.
74. Garigan D, Hsu AL, Fraser AG, et al.: Genetic analysis of tissue aging in Caenorhabditis elegans: a role for heat-shock factor and bacterial proliferation. Genetics. 2002; 161(3): 1101-12.
75. Abegglen LM, Caulin AF, Chan A, et al.: Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans. JAMA. 2015; 314(17): 1850-60.
76. Toth ML, Melentijevic I, Shah L, et al.: Neurite sprouting and synapse deterioration in the aging Caenorhabditis elegans nervous system. J Neurosci. 2012; 32(26): 8778-90.
77. Tank EM, Rodgers KE, Kenyon C: Spontaneous age-related neurite branching in Caenorhabditis elegans. J Neurosci. 2011; 31(25): 9279-88.
78. Gerstbrein B, Stamatas G, Kollias N, et al.: In vivo spectrofluorimetry reveals endogenous biomarkers that report healthspan and dietary restriction in Caenorhabditis elegans. Aging Cell. 2005; 4(3): 127-37.
79. Luo S, Shaw WM, Ashraf J, et al.: TGF-beta Sma/Mab signaling mutations uncouple reproductive aging from somatic aging. PLoS Genet. 2009; 5(12): e1000789.
80. Sujkowski A, Bazzell B, Carpenter K, et al.: Endurance exercise and selective breeding for longevity extend Drosophila healthspan by overlapping mechanisms. Aging (Albany NY). 2015; 7(8): 535-52.
81. Miller RA, Kreider J, Galecki A, et al.: Preservation of femoral bone thickness in middle age predicts survival in genetically heterogeneous mice. Aging Cell. 2011; 10(3): 383-91.
82. Dai DF, Rabinovitch PS: Cardiac aging in mice and humans: the role of mitochondrial oxidative stress. Trends Cardiovasc Med. 2009; 19(7): 213-20.
83. Miller RA, Austad S, Burke D, et al.: Exotic mice as models for aging research: polemic and prospectus. Neurobiol Aging. 1999; 20(2): 217-31.
84. Austad SN: Comparative biology of aging. J Gerontol A Biol Sci Med Sci. 2009; 64(2): 199-201.
85. Kim EB, Fang X, Fushan AA, et al.: Genome sequencing reveals insights into physiology and longevity of the naked mole rat. Nature. 2011; 479(7372): 223-7.
86. Favreau JT, Nguyen BT, Gao I, et al.: Murine ultrasound imaging for circumferential strain analyses in the angiotensin II abdominal aortic aneurysm model. J Vasc Surg. 2012; 56(2): 462-9.
87. Benedetti MG, Foster AL, Vantipalli MC, et al.: Compounds that confer thermal stress resistance and extended lifespan. Exp Gerontol. 2008; 43(10): 882-91.
88. Quick KL, Ali SS, Arch R, et al.: A carboxyfullerene SOD mimetic improves cognition and extends the lifespan of mice. Neurobiol Aging. 2008; 29(1): 117-28.
89. Hefti FF, Bales R: Regulatory issues in aging pharmacology. Aging Cell. 2006; 5(1): 3-8.
90. Wood JG, Rogina B, Lavu S, et al.: Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004; 430(7000): 686-9.
91. Loffredo FS, Steinhauser ML, Jay SM, et al.: Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013; 153(4): 828-39.
92. Smith SC, Zhang X, Zhang X, et al.: GDF11 does not rescue aging-related pathological hypertrophy. Circ Res. 2015; 117(11): 926-32.
93. Sinha M, Jang YC, Oh J, et al.: Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science. 2014; 344(6184): 649-52.
94. Egerman MA, Cadena SM, Gilbert JA, et al.: GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration. Cell Metab. 2015; 22(1): 164-74.
95. Miller RA, Harrison DE, Astle CM, et al.: Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2011; 66(2): 191-201.
96. Katsimpardi L, Litterman NK, Schein PA, et al.: Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science. 2014; 344(6184): 630-4.
97. Nadon NL, Strong R, Miller RA, et al.: Design of aging intervention studies: the NIA interventions testing program. Age (Dordr). 2008; 30(4): 187-99.
98. Hall SS: A Trial for the ages. Science. 2015; 349(6254): 1274-8.
99. Martin-Montalvo A, Mercken EM, Mitchell SJ, et al.: Metformin improves healthspan and lifespan in mice. Nat Commun. 2013; 4: 2192.
100. Onken B, Driscoll M: Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS One. 2010; 5(1): e8758.
101. Mannick JB, Del Giudice G, Lattanzi M, et al.: mTOR inhibition improves immune function in the elderly. Sci Transl Med. 2014; 6(268): 268ra179.
102. Melov S, Ravenscroft J, Malik S, et al.: Extension of life-span with superoxide dismutase/catalase mimetics. Science. 2000; 289(5484): 1567-9.
103. Keaney M, Gems D: No increase in lifespan in Caenorhabditis elegans upon treatment with the superoxide dismutase mimetic EUK-8. Free Radic Biol Med. 2003; 34(2): 277-82.
104. Kang HL, Benzer S, Min KT: Life extension in Drosophila by feeding a drug. Proc Natl Acad Sci U S A. 2002; 99(2): 838-43.
105. Wilson MA, Shukitt-Hale B, Kalt W, et al.: Blueberry polyphenols increase lifespan and thermotolerance in Caenorhabditis elegans. Aging Cell. 2006; 5(1): 59-68.
106. Petrascheck M, Ye X, Buck LB: An antidepressant that extends lifespan in adult Caenorhabditis elegans. Nature. 2007; 450(7169): 553-6.
107. Zarse K, Ristow M: Antidepressants of the serotonin-antagonist type increase body fat and decrease lifespan of adult Caenorhabditis elegans. PLoS One. 2008; 3(12): e4062.
108. McColl G, Killilea DW, Hubbard AE, et al.: Pharmacogenetic analysis of lithiuminduced delayed aging in Caenorhabditis elegans. J Biol Chem. 2008; 283(1): 350-7.
109. Harrison DE, Strong R, Sharp ZD, et al.: Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009; 460(7253): 392-5.
110. Anisimov VN, Zabezhinski MA, Popovich IG, et al.: Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle. 2011; 10(24): 4230-6.
111. Alavez S, Vantipalli MC, Zucker DJ, et al.: Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan. Nature. 2011; 472(7342): 226-9.
112. Moskalev A, Shaposhnikov M: Pharmacological inhibition of NF-κB prolongs lifespan of Drosophila melanogaster. Aging (Albany NY). 2011; 3(4): 391-4.